ArticleJTCVS open2026

Clinical effect of proprotein convertase subtilisin/kexin type 9 inhibition in patients undergoing coronary artery bypass surgery.

Giuseppe Nasso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.